Ignite Creation Date:
2025-12-24 @ 9:09 PM
Ignite Modification Date:
2026-05-30 @ 2:59 PM
Study NCT ID:
NCT01363804
Status:
COMPLETED
Last Update Posted:
2012-06-05
First Post:
2011-05-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Study to Evaluate the Effect of Rifampin on the Pharmacokinetics of Tivozanib in Healthy Subjects
Sponsor:
AVEO Pharmaceuticals, Inc.
Organization: